AGI-14100
Product Specifications
CAS Number
1448346-43-7
Target
Dehydrogenase, Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolism
Purity
>99.99%
Bioactivity
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Smiles
N([C@H](C(NC1CC(F)(F)C1)=O)C2=C(Cl)C=CC=C2)(C(=O)[C@H]3N(C(=O)CC3)C4=CC(C#N)=CC=N4)C5=CC(F)=CC(F)=C5
Molecular Formula
C29H22ClF4N5O3
Molecular Weight
599.96
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6355550-01 0.2 mL
TIFAB, ID (TIFAB, TRAF-interacting protein with FHA domain-containing protein B, TIFA-like protein) (FITC)
Sign In for Pricing
View Details MBS6355550-02 5x 0.2 mL
TIFAB, ID (TIFAB, TRAF-interacting protein with FHA domain-containing protein B, TIFA-like protein) (FITC)
Sign In for Pricing
View Details MBS7011948-01 0.02 mg
Recombinant Yarrowia lipolytica Cytochrome oxidase assembly protein 3, mitochondrial (COA3)
Sign In for Pricing
View Details MBS7011948-02 0.1 mg
Recombinant Yarrowia lipolytica Cytochrome oxidase assembly protein 3, mitochondrial (COA3)
Sign In for Pricing
View Details MBS7011948-03 5x 0.1 mg
Recombinant Yarrowia lipolytica Cytochrome oxidase assembly protein 3, mitochondrial (COA3)
Sign In for Pricing
View Details 